Rationale: Obstructive sleep apnea (OSA) is linked to increased cardiovascular risk, but the
impact of mild forms of OSA and their treatment on cardiovascular outcomes remains …

Patients with obstructive sleep apnoea syndrome (OSAS) are subject to an increased
cardiovascular morbidity including myocardial infarction and stroke. Platelets play an important …

Background: Obstructive sleep apnea syndrome (OSAS) is associated with an increased
cardiovascular morbidity, including pulmonary hypertension. Little is known about factors …

Recent studies suggest an association of obstructive sleep apnoea (OSA) with cardiovascular
risk factors, such as dyslipidaemia. The present study analyses the effects of OSA and its …

Obstructive sleep apnoea syndrome (OSAS) is a common disorder in obesity. Leptin, an
adipocyte-derived signalling factor, plays an important role in metabolic control. There is …

There is conclusive evidence that obstructive sleep apnoea syndrome (OSAS) influences
right heart haemodynamics and can also induce pulmonary hypertension. It is not known, …

In obstructive sleep apnoea syndrome (OSAS), prosthetic mandibular advancement devices
(MAD) seem to be a promising treatment alternative to conventional continuous positive …

Background. It is well known that the quality of life of haemodialysis recipients is often severely
compromised. So far, the influence of sleep‐related breathing disorders on the quality of …

Background: Patients with obstructive sleep apnea syndrome (OSAS) are subject to an
increased cardiovascular morbidity including systemic hypertension. Little is known about the …

… Sanner et al 16 reported a reduction of the mean arterial BP by an average of 4.6 mm Hg
during CPAP therapy for 9 months in 52 patients with a mean AHI of 32 events/h. Becker et al …